Hansa Biopharma: Directed Share Issue of USD71m - Redeye
Bildkälla: Stockfoto

Hansa Biopharma: Directed Share Issue of USD71m - Redeye

Redeye is optimistic after Hansa’s directed share issue tonight, which was expanded from USD60m to USD71m due to strong demand.

Redeye is optimistic after Hansa’s directed share issue tonight, which was expanded from USD60m to USD71m due to strong demand.
Börsvärldens nyhetsbrev